Sponsored by
The Cureus Journal of Medical Science presents a publishing competition
CT or CBCT Guided Online Adaptive Radiotherapy Clinical Case Reports
$7,000
IN HONORARIUMS
The Cureus Journal of Medical Science is proud to introduce the CT or CBCT Guided Online Adaptive Radiotherapy Clinical Case Reports publishing competition.
Online adaptive radiotherapy is the process of altering a patient’s treatment plan based on anatomy imaged at the time of treatment, while the patient is on the treatment table. By adapting plans to account for changes in the target and surrounding tissues, ART can help maintain therapeutic doses to treatment targets and reduce radiation exposure to normal tissues. Thus, online ART represents a significant advance relative to non-ART image-guided and intensity-modulated radiotherapy.
The current competition is restricted to case reports that illustrate online ART based on daily CT or CBCT images. Authors are encouraged to submit cases treated with radiotherapy anywhere in the body, describing the patient and their disease, the radiotherapy regimen (fractions, doses), dosimetry before and after ART, clinical outcomes (toxicity and disease control) and practical considerations (auto-contouring accuracy, time requirements of re-planning, etc.). Reports should focus on unique cases or case series that highlight a significant advantage of online ART, or that show that daily ART allows clinicians to treat more effectively compared to a non-adaptive approach. Competition submissions should clearly illustrate, with images and analyses, advantages of CT/CBCT-guided online ART compared to non-ART treatment.
Eligible submissions shall include case reports and limited case series (featuring a maximum of five cases).
Our goal is to share the results with the Cureus global community of radiation oncologists, neurosurgeons (where applicable), medical physicists, dosimetrists, radiation therapists, as well as patients who might benefit. To encourage dissemination and cross-disciplinary awareness, all published materials will be Open Access and indexed with PubMed Central.
The winner of this competition will be determined by ratings from the medical community using Cureus Scholarly Impact Quotient™ (SIQ™) crowdsourcing technology.
Program administration has been enabled through the financial support of http://www.varian.com. Article selection, editorial review, peer review, publication, and competition winner determination are strictly independent of the sponsor.
Peer Review Panel
All article submissions will undergo independent pre-publication peer review by a world-class team of experts.
Indrin J. Chetty
Professor, PhD | Radiation OncologyRadiation Oncology, Cedars-Sinai Medical Center, Los Angeles, USA
James Robar
Professor, PhD, MSc | Radiation OncologyDepartment of Radiation Oncology, Department of Physics & Atmospheric Science, Dalhousie University, Halifax, CAN
Jyoti Mayadev
MD, Professor | Radiation OncologyDepartment of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, San Diego, USA
Alex Price
MSc | Radiation OncologyDepartment of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, USA
Carlos Cardenas
PhD, Assistant Professor | Medical PhysicsDepartment of Radiation Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA
Dennis Stanley
Associate Professor, PhD | Medical PhysicsDepartment of Radiation Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA
Evan Osmundson
MD, PhD, Associate Professor | Radiation OncologyDepartment of Radiation Oncology, Vanderbilt University Medical Center, Nashville, USA
Harjot Kaur Bajwa
MD | Radiation OncologyRadiation Oncology, American Oncology Institute, Hyderabad, IND
Hyun Kim
Associate Professor, MD | Radiation OncologyDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, USA
Lauren E. Henke
Associate Professor, MD | Radiation OncologyRadiation Oncology, University Hospitals, Case Western Reserve University, Cleveland, USA
Malolan S. Rajagopalan
MD | Radiation OncologyRadiation Oncology, Mount Carmel Health System, Columbus, USA
Sean P. Collins
MD, PhD | Radiation OncologyDepartment of Radiation Medicine, Georgetown University Hospital
Eric Horwitz
MD | Radiation OncologyDepartment of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, USA
Hefei Liu
Resident Physician, MD | Radiation OncologyRadiation Oncology, University of Pennsylvania, Philadelphia, USA
Competition Entries
The entry period is now closed. Competition entries appear below as they are published. Now is your chance to score and discuss these articles. Honorariums will be awarded to the authors of the three highest-scoring cases!
Requirements
Competition entry and article submission is entirely free. All submitted work must be previously unpublished. Only case reports/series are eligible for submission.
All articles must be submitted and formatted via the template-driven, self-publishing Cureus platform. Authors are encouraged to include supporting images, charts, tables and/or videos within their article submissions. For additional information on publishing with Cureus, please refer to our Author Guide.
Other Stipulations
- All clinical studies must be compliant with applicable regulatory, ethics / IRB, and other rules governing protection of human subjects.
- All non-clinical studies must be compliant with applicable AAUC, AAALAC, and other related regulations.
- This program is not intended to promote or otherwise encourage unapproved, un-cleared use of products or any product for unapproved new use.
- This program in no way promotes or purports to encourage any research that is not in compliance with any local, federal, or other applicable governing laws.
Statement of Independence
Cureus Publishing Competitions are intended to encourage medical discovery and document clinical experiences – be they positive, negative, or neutral and foster broader educational outreach through Open Access publication that is free to both authors and readers.
Article submissions must adhere to the described “call for articles” and are open to any and all related manufacturer or vendor technologies.
As a firewall to ensure objective and credible science, article selection, editorial review, peer review and publication are strictly independent of the sponsoring company.
Winning articles are selected exclusively via peer review panel and community crowdsourced scoring. Neither the sponsoring company, nor Cureus, can determine the competition outcome.
Awards
Winning Article Honorariums
The authors of the three highest-rated cases will be awarded an honorarium for Cureus Scientific Excellence™ which will be determined by Cureus SIQ™ (Scholarly Impact Quotient™) ratings.
1st Place: $3,000 USD
2nd Place: $2,000 USD
3rd Place: $2,000 USD
Subsequent to formal editorial and peer review, published articles undergo SIQ scoring - Cureus’ unique crowdsourced, post-publication rating system. In addition to measuring engagement, SIQ allows the community-at-large to rate the quality of individual articles. Reviewers assign scores from 1 to 10 on criteria including clarity and rationale, clinical importance, study design and methods, data analysis, novelty of conclusions and quality of presentation.
Aggregated community SIQ scores allow clinicians and researchers to quickly assess article quality in a manner similar to that of Amazon® and Yelp® community reviews.
Eligible articles must receive a minimum of five scores. (A Cureus user can assign only one score per article.) As engagement and scoring is critical to winning, authors are highly encouraged to share their published articles via social media and email.
Sunshine Act Reporting
Section 6002 of the Affordable Care Act requires applicable manufacturers of covered drugs, devices, biologicals, and medical supplies to report payments or other transfers of value made to physicians and teaching hospitals. For winning article and referral awards paid to “covered recipients,” award fees shall be supplied to Varian for subsequent Sunshine Act reporting.
Key Dates
- Tuesday, April 23, 2024 – Competition begins; articles may now be submitted
- Tuesday, July 23, 2024 – Article submission deadline @ 5:00 pm ET
- Tuesday, August 27, 2024 – Peer review of all eligible articles concludes
- Tuesday, September 24, 2024 – Crowdsourced scoring (SIQ) complete @ 5:00 pm ET
- Thursday, September 26, 2024 – Winning articles announced
